Silverman, Lee
Agios Pharmaceuticals (United States)
3 papers on CoChat
Most cited papers
- Verified
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Rohle, D., Popovici-Muller, J., Palaskas, N., Turcan, S., Grommes, C., Campos, C., Tsoi, J., Clark, O., Oldrini, B., Komisopoulou, E., et al. (2013) · Science
Glioma Diagnosis and TreatmentCancer, Hypoxia, and Metabolism
Cited by 1,153
- Verified
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
Yen, K., Travins, J., Wang, F., David, M. D., Artin, E., Straley, K., Padyana, A., Gross, S., DeLaBarre, B., Tobin, E., et al. (2017) · Cancer Discovery
Acute Myeloid Leukemia ResearchGlioma Diagnosis and Treatment
Cited by 471
- Verified
A Critical Review of the Effectiveness of Rodent Pharmaceutical Carcinogenesis Testing in Predicting for Human Risk
Alden, C. L., Lynn, A., Bourdeau, A., Morton, D., Sistare, F. D., Kadambi, V. J., & Silverman, L. (2011) · Veterinary Pathology
Carcinogens and Genotoxicity AssessmentImmunotoxicology and immune responses
Cited by 69
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free